|
Gastric and Esophageal Malignancies in Northern Iran (GEMINI): Case-Control Study
|
ZIA CP000185 - 10318
|
$9,297
|
Abnet, Christian
|
DCEG (NCI)
|
|
The Golestan Cohort Study
|
ZIA CP000185 - 10361
|
$32,990
|
Abnet, Christian
|
DCEG (NCI)
|
|
Randomized Placebo-Controlled Trial of a Gastrin Receptor Antagonist in Barretts
|
1R03CA186218-01A1
|
$81,186
|
ABRAMS, JULIAN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
MMC, VICC & TSU: Partners in Eliminating Cancer Disparities ( 1 of 3)
|
5U54CA163069-05
|
$870,850
|
ADUNYAH, SAMUEL
|
MEHARRY MEDICAL COLLEGE
|
|
Colon Cancer Chemoprevention by Flavonoid Silibinin
|
5R01CA112304-10
|
$286,515
|
AGARWAL, RAJESH
|
UNIVERSITY OF COLORADO DENVER
|
|
Molecular mechanism of bitter melon juice efficacy against pancreatic cancer.
|
5R01CA195708-02
|
$387,195
|
AGARWAL, RAJESH
|
UNIVERSITY OF COLORADO DENVER
|
|
Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer Center
|
5U10CA180791-02
|
$737,200
|
AGHAJANIAN, CAROL
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
SPARC as a regulator of collagen signaling in Pancreatic Cancer
|
5F31CA168350-03
|
$30,485
|
AGUILERA, KRISTINA
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
(PQB6)An Integrative Computational and Bioengineered Tissue Model of Metastasis
|
5R01CA180149-03
|
$577,096
|
AGUS, DAVID
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Studying Colonic Stem-Cell Niche Using Microengineered Gradient-Generating Device
|
5F31CA183309-02
|
$33,265
|
AHMAD, ASAD
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
APC Tumor Suppressor in Cell Differentiation and Death
|
5R01CA105038-10
|
$262,280
|
AHMED, YASMATH
|
DARTMOUTH COLLEGE
|
|
Prospective Study of Human Oral Microbiome and Pancreatic Cancer Risk
|
5R01CA164964-02
|
$593,181
|
AHN, JIYOUNG
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
(PQD3)Molecular Profiles associated with Long-Term Survival in pancreas Cancer
|
5R01CA185357-02
|
$490,967
|
AHUJA, NITA
|
JOHNS HOPKINS UNIVERSITY
|
|
Elucidating the role and regulation of epithelial plasticity in metastasis
|
5F31CA177163-02
|
$29,766
|
AIELLO, NICOLE
|
UNIVERSITY OF PENNSYLVANIA
|
|
Inhibition of Hedgehog Signaling in Gli-1+Adeno CA of the Esoph or GE junction
|
5R01CA172741-03
|
$279,793
|
AJANI, JAFFER
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
ATBC Study
|
ZIA CP010195 - 03031
|
$871,993
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
Medical University of South Carolina - Cancer Center Support Grant
|
3P30CA138313-07S1
|
$34,031
|
ALBERG, ANTHONY
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Medical University of South Carolina - Cancer Center Support Grant
|
3P30CA138313-07S2
|
$250,000
|
ALBERG, ANTHONY
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Medical University of South Carolina - Cancer Center Support Grant
|
3P30CA138313-07S3
|
$124,997
|
ALBERG, ANTHONY
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Medical University of South Carolina - Cancer Center Support Grant
|
5P30CA138313-07
|
$1,495,000
|
ALBERG, ANTHONY
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Naional Cancer Institute, Naitonal Clinical Trials Network U10 Lead Academic Sit
|
5U10CA180790-02
|
$1,295,864
|
ALBERTS, STEVEN
|
MAYO CLINIC ROCHESTER
|
|
Southeast Michigan Community Network Program
|
3U54CA153606-05S2
|
$256,783
|
ALBRECHT, TERRANCE
|
WAYNE STATE UNIVERSITY
|
|
Mesothelin-targeted immunotoxins in Pancreatic Cancer
|
ZIA BC 011652
|
$342,411
|
Alewine, Christine
|
CCR (NCI)
|
|
Clinical Support
|
ZIE BC 011653
|
$18,022
|
Alewine, Christine
|
CCR (NCI)
|
|
Single-Cell Measurement of Lipid Signaling in Colorectal Cancer
|
5R01CA177993-02
|
$599,508
|
ALLBRITTON, NANCY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Dosage-Dependent Hedgehog Signaling in Pancreatic Cancer
|
1R01CA198074-01
|
$392,629
|
ALLEN, BENJAMIN
|
UNIVERSITY OF MICHIGAN
|
|
Tumor Embolization Using A Novel Catheter With Integrated Flow Regulation
|
1R43CA192428-01A1
|
$221,873
|
ALLEN, MICHAEL
|
EMBOLX, INC.
|
|
INFLAMMATORY CHEMOKINE CCL3 IN THE TUMOR MICROENVIRONMENT LEADS TO ENHANCED ANTIT
|
5F31CA192874-02
|
$31,104
|
ALLEN, FREDERICK
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Biomarker validation for intraductal papillary mucinous neoplasms of the pancreas
|
5R01CA182076-02
|
$437,758
|
ALLEN, PETER
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
MYC is a critical downstream effector in KRAS-driven pancreatic cancer
|
1F32CA192769-01
|
$56,529
|
ALLEN-PETERSEN, BRITTANY
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Consolidated Basic Cancer Research Program
|
3P30CA010815-46S1
|
$138,748
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Consolidated Basic Cancer Research Program
|
5P30CA010815-46
|
$2,578,347
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Oncogenic Disruption of Circadian Rhythm and Chronotherapy
|
5F32CA180370-02
|
$57,962
|
ALTMAN, BRIAN
|
UNIVERSITY OF PENNSYLVANIA
|
|
NCTN Deep South Research Consortium
|
3U10CA180855-02S1
|
$199,999
|
ALVAREZ, RONALD
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
NCTN Deep South Research Consortium
|
5U10CA180855-02
|
$497,800
|
ALVAREZ, RONALD
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
HLTF gene silencing: a novel determinant of sensitivity to autophagy inhibition
|
5R01CA169134-03
|
$312,942
|
AMARAVADI, RAVI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$768,848
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
High Resolution Microendoscopy for the Management of Esophageal Neoplasia
|
5R01CA181275-02
|
$589,926
|
ANANDASABAPATHY, SHARMILA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Novel Dual Notch/PXR Targeting for Colon Cancer Therapy
|
5R01CA182872-02
|
$67,777
|
ANANT, SHRIKANT
|
UNIVERSITY OF KANSAS MEDICAL CENTER
|
|
Bitter Melon Component and Colon Cancer Prevention
|
5R01CA190291-02
|
$544,710
|
ANANT, SHRIKANT
|
UNIVERSITY OF KANSAS MEDICAL CENTER
|
|
Whole exome sequencing of oropharyngeal carcinoma (OPX-WES)
|
1R03CA183010-01A1
|
$56,500
|
ANANTHARAMAN, DEVASENA
|
INTERNATIONAL AGENCY FOR RES ON CANCER
|
|
Role of Id1 in adiposity, energy balance and obesity associated liver tumorigene
|
5K22CA168828-03
|
$89,879
|
ANDE, SATYANARAYANA
|
GEORGIA REGENTS UNIVERSITY
|
|
Obesity and mortality after breast cancer diagnosis by race/ethnicity in the WHI
|
3UM1CA173642-03S1
|
$113,842
|
ANDERSON, GARNET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Women's Health Initiative Cancer Survivor Cohort
|
5UM1CA173642-03
|
$2,539,856
|
ANDERSON, GARNET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Hutchinson Center as Lead Academic Participating Site (U10)
|
5U10CA180828-02
|
$557,728
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
2/2 SDSU/UCSD Cancer Center Comprehensive Partnership
|
2U54CA132384-06A1
|
$1,266,713
|
ARREDONDO, ELVA
|
SAN DIEGO STATE UNIVERSITY
|
|
Reversing Cellular immortality in cancer
|
1R35CA197563-01
|
$632,529
|
ARTANDI, STEVEN
|
STANFORD UNIVERSITY
|
|
T Cell Alternative p38 Activation Pathway
|
ZIA BC 010774
|
$461,571
|
Ashwell, Jonathan
|
CCR (NCI)
|
|
Cancer Center Support Grant
|
3P30CA082103-17S2
|
$50,000
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-17S3
|
$124,967
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|